Close Menu

NEW YORK (GenomeWeb) – Karius has raised $50 million in a Series A financing round led by Data Collective and Lightspeed Venture Partners. New investors Tencent and Khosla Ventures, as well as existing investors Innovation Endeavors and Spectrum 28, also participated.

The Redwood City, California-based firm, which spun out from Stanford University in 2014, said it plans to use the funding to support new and ongoing clinical trials, scale up its laboratory capacity, and help commercialize its infectious disease test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

May
10
Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
13
Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.